Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke-Reference-Cited by-同舟云学术

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke

Published:2023 Issue:38 Volume:38 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Kim Tae Jung¹²^ORCID,Lee Ji Sung³^ORCID,Yoon Jae Sun¹^ORCID,Park Soo-Hyun⁴^ORCID,Oh Mi Sun⁵^ORCID,Jung Keun-Hwa¹^ORCID,Yu Kyung-Ho⁵^ORCID,Lee Byung-Chul⁵^ORCID,Ko Sang-Bae¹²^ORCID,Yoon Byung-Woo⁶^ORCID

Affiliation:

1. Department of Neurology, Seoul National University Hospital, Seoul, Korea.

2. Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Korea.

3. Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

4. Department of Neurology, Gangdong Sacred Heart Hospital, Seoul, Korea.

5. Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.

6. Department of Neurology, Uijeongbu Eulji Medical Center, Uijeongbu, Korea.

Funder

Ministry of Health and Welfare

National Research Foundation of Korea

Publisher

XMLink

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2023.38.e294

Reference39 articles.

1. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project.

2. Risk and Cumulative Risk of Stroke Recurrence

3. Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose

4. Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis

5. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association